Venus Medtech (Hangzhou), Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-798.00
-798.00
-1,328.00
-440.00
-209.00
-432.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
129.00
93.00
-163.00
-176.00
-155.00
-87.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-195.00
-484.00
-887.00
-526.00
-265.00
-352.00
Cash Flow from Investing Activities
-30.00
-406.00
-1,249.00
-753.00
-312.00
-35.00
Cash Flow from Financing Activities
-504.00
-154.00
783.00
1,620.00
1,020.00
2,931.00
Net Cash Inflow / Outflow
-722.00
-1,017.00
-1,248.00
297.00
333.00
2,549.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
7.00
28.00
105.00
-41.00
-109.00
5.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Venus Medtech (Hangzhou), Inc.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-798.594829211215
109.890423333193
-907.00
-826.72%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
129.504032644098
-13.8704756171591
142.00
1033.67%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-195.223176633662
187.219436228294
-382.00
-204.28%
Cash Flow from Investing Activities
-30.1934655660632
-869.394646126754
839.00
96.53%
Cash Flow from Financing Activities
-504.965328184167
-43.4502704883648
-461.00
-1062.17%
Net Cash Inflow / Outflow
-722.642780596096
-724.772196222774
2.00
0.29%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
7.73918978779657
0.853284164050981
7.00
806.99%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 59.72% vs 45.42% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-195.22
-484.61
59.72%






